?IIb-Integrin (CD41) associated with blood eosinophils is a potential biomarker for disease activity in eosinophilic esophagitis - 08/06/20
![](/templates/common/images/mail.png)
This study was funded by the National Institutes of Health (grants R21 AI122103 [to S.K.M., E.A.G., and M.W.J.] and T32 AI007635 [to E.L.A.]); Program Project (grant P01 HL088594 [to N.J. Jarjour, D.F.M., and S.K.M.]); Clinical and Translational Science Award (grant U11 RR025011 [to M. K. Drezner]), and University of Wisconsin Carbone Cancer Center (support grant P30 CA014520 [to H. H. Bailey]). The funding source had no involvement in the study design; the data collection, analysis, or interpretation; the writing of the report; or the decision to submit the article for publication. |
|
Disclosure of potential conflict of interest: M. W. Johansson reports receiving a grant from Hoffmann-La Roche, having received a speaker fee and been an advisory board member for Genentech, and receiving consulting fees from Guidepoint Global unrelated to this work. S. K. Mathur reports receiving consulting and speaker fees from AstraZeneca unrelated to this work. The rest of the authors declare that they have no relevant conflicts of interest. |
Vol 145 - N° 6
P. 1699-1701 - Giugno 2020 Ritorno al numeroBenvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?